🇺🇸 FDA
Pipeline program

UP421

UP421-ET1D

Phase 1 mab active

Quick answer

UP421 for Type1diabetes is a Phase 1 program (mab) at Sana Biotechnology with 1 ClinicalTrials.gov record(s).

Program details

Company
Sana Biotechnology
Indication
Type1diabetes
Phase
Phase 1
Modality
mab
Status
active

Clinical trials